Upadacitinib for Alopecia: Current Evidence and Clinical Insights

By afschroeder • August 7, 2025

Stirrat T, Thakker S, Bejugam D, Goh C, Lipner SR. Upadacitinib for Alopecia: Current Evidence and Clinical Insights. Skin Appendage Disord. 2025 Aug;11(4):320-334. doi: 10.1159/000544868. Epub 2025 Feb 25. PMID: 40771447; PMCID: PMC12324716.

Tags: alopecia areata, Dermatology, hair loss, Janus kinase 1 inhibitors, Publications, scoping review, Upadacitinib

Complete genomes of the hydrogenotrophic methanogen species -Methanospirillum stamsii Pt1 and Methanospirillum lacunae Ki8-1

Humm E, Chettiyar R, Rubbi L, Del Vecchio G, Pellegrini M, Ha SM, Gunsalus RP. Complete genomes of the hydrogenotrophic methanogen species-Methanospirillum stamsii Pt1 and Methanospirillum lacunae Ki8-1.[...]

SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement

Stein Gold L, Gottlieb AB, Armstrong AW, Alkousakis T, Bissonnette R, Langley RG, Krueger J, Papp K, Choi O, Rowland K, Chan D, Jeyarajah J,[...]

A Nationwide Survey of Dermatology Faculty and Mentors on Their Advice for the Dermatology Match Process

D'Amiano AJ, Rohr B, Glick B, Hogeling M, Keller M, Sunshine J. A Nationwide Survey of Dermatology Faculty and Mentors on Their Advice for the[...]